IMPURITIES AVAILABLE FOR 'Efaproxiral'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Efaproxiral. Efaproxiral, also known as RSR13, is an allosteric hemoglobin modifier developed to enhance oxygen release from hemoglobin to tissues. It works by binding noncovalently to the hemoglobin molecule and decreasing its oxygen affinity, thereby improving tissue oxygenation, particularly in hypoxic conditions. Efaproxiral has been investigated as a radiation sensitizer to enhance the effectiveness of radiotherapy in treating hypoxic tumors such as brain metastases. By increasing oxygen delivery to tumor tissues, it helps improve the therapeutic impact of radiation. The compound is administered intravenously and has shown promise in preclinical and early clinical studies. Common side effects observed include fatigue, headache, and mild hypotension. However, its clinical use remains limited due to inconsistent efficacy outcomes in large trials. Efaproxiral represents a novel approach to modifying oxygen transport for therapeutic benefit in oncology and ischemic conditions. Buy high quality Efaproxiral from Omsynth Lifesciences.